Empirical analysis of drug patenting in multiple high-value cohorts*
Abstract:
This study was designed to empirically investigate two related phenomena within the context of the emerging linkage regulation model of intellectual property protection. The first was to probe the legal nexus between drug approval, drug patenting, and patent listing under the linkage regime for high-value pharmaceuticals as vetted by regulators and the market. While the patent regime has been claimed by both pharmaceutical firms and regulators to be integral for innovative drug development, the role of drug approval-drug patenting linkage in pharmaceutical innovation is far less clear. Evidence relating to drug approval-drug patenting linkage, especially for high-value ...
Get Patently Innovative now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
